The Chinese pharmaceutical industry
is expected to
experience exponential growth over the next few years.
Although recent policy changes (e.g. price cuts)
may create barriers, there are a growing number of
opportunities for Chinese and foreign drug companies.
Recent economic growth, increasing health care
expenditure, and a rising incidence of diseases linked
to changing lifestyles are all considered to be factors in China's predicted growth. In a
recent report, financial analysts at Merrill Lynch estimated that
China's pharmaceutical
industry will grow at an annual rate of 24%
between 2010 and 2020.
